Showing 19,821 - 19,840 results of 65,434 for search '(( 5 we decrease ) OR ( 5 ((point decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.28s Refine Results
  1. 19821

    Table 5_Characteristics of pediatric interventional drug trials registered between 2015 and 2024 on ClinicalTrials.gov.docx by Yinghong Zhou (6873053)

    Published 2025
    “…Among these, 1,975 (67.5%) enrolled no more than 100 participants, and 153 (5.2%) were restricted to either males or females, with this gender-specific enrollment correlated with disease epidemiology. …”
  2. 19822
  3. 19823

    DataSheet_1_Sex-Related Differences in Innate and Adaptive Immune Responses to SARS-CoV-2.pdf by Sudhanshu Agrawal (239476)

    Published 2021
    “…The mechanisms are not clear but differential immune responses, particularly the initial innate immune response, between sexes may be playing a role. The early innate immune responses to SARS-CoV-2 have not been studied because of the gap in timing between the patient becoming infected, showing symptoms, and getting the treatment. …”
  4. 19824

    Changes in clinical practice perceptions and mental health of sports medicine physicians due to the SARS-CoV-2 pandemic by Daniel M. Cushman (11248716)

    Published 2021
    “…<p>The SARS-CoV-2 pandemic has had an immense impact on healthcare, but little has been published on its impact on sports medicine physicians. …”
  5. 19825
  6. 19826
  7. 19827
  8. 19828

    Image 7_SARS-CoV-2 post-acute sequelae linked to inflammation via extracellular vesicles.jpeg by Sara Bachiller (15231716)

    Published 2025
    “…Background<p>Despite the efficacy of SARS-CoV-2 vaccines in reducing mortality and severe cases of COVID-19, a proportion of survivors experience long-term symptoms, known as post-acute sequelae of SARS-CoV-2 infection (PASC). …”
  9. 19829

    Image 8_SARS-CoV-2 post-acute sequelae linked to inflammation via extracellular vesicles.jpeg by Sara Bachiller (15231716)

    Published 2025
    “…Background<p>Despite the efficacy of SARS-CoV-2 vaccines in reducing mortality and severe cases of COVID-19, a proportion of survivors experience long-term symptoms, known as post-acute sequelae of SARS-CoV-2 infection (PASC). …”
  10. 19830

    Image 4_SARS-CoV-2 post-acute sequelae linked to inflammation via extracellular vesicles.jpeg by Sara Bachiller (15231716)

    Published 2025
    “…Background<p>Despite the efficacy of SARS-CoV-2 vaccines in reducing mortality and severe cases of COVID-19, a proportion of survivors experience long-term symptoms, known as post-acute sequelae of SARS-CoV-2 infection (PASC). …”
  11. 19831

    Image 9_SARS-CoV-2 post-acute sequelae linked to inflammation via extracellular vesicles.jpeg by Sara Bachiller (15231716)

    Published 2025
    “…Background<p>Despite the efficacy of SARS-CoV-2 vaccines in reducing mortality and severe cases of COVID-19, a proportion of survivors experience long-term symptoms, known as post-acute sequelae of SARS-CoV-2 infection (PASC). …”
  12. 19832

    Image 3_SARS-CoV-2 post-acute sequelae linked to inflammation via extracellular vesicles.jpeg by Sara Bachiller (15231716)

    Published 2025
    “…Background<p>Despite the efficacy of SARS-CoV-2 vaccines in reducing mortality and severe cases of COVID-19, a proportion of survivors experience long-term symptoms, known as post-acute sequelae of SARS-CoV-2 infection (PASC). …”
  13. 19833

    Image 1_SARS-CoV-2 post-acute sequelae linked to inflammation via extracellular vesicles.jpeg by Sara Bachiller (15231716)

    Published 2025
    “…Background<p>Despite the efficacy of SARS-CoV-2 vaccines in reducing mortality and severe cases of COVID-19, a proportion of survivors experience long-term symptoms, known as post-acute sequelae of SARS-CoV-2 infection (PASC). …”
  14. 19834

    Image 2_SARS-CoV-2 post-acute sequelae linked to inflammation via extracellular vesicles.jpeg by Sara Bachiller (15231716)

    Published 2025
    “…Background<p>Despite the efficacy of SARS-CoV-2 vaccines in reducing mortality and severe cases of COVID-19, a proportion of survivors experience long-term symptoms, known as post-acute sequelae of SARS-CoV-2 infection (PASC). …”
  15. 19835

    Image 6_SARS-CoV-2 post-acute sequelae linked to inflammation via extracellular vesicles.jpeg by Sara Bachiller (15231716)

    Published 2025
    “…Background<p>Despite the efficacy of SARS-CoV-2 vaccines in reducing mortality and severe cases of COVID-19, a proportion of survivors experience long-term symptoms, known as post-acute sequelae of SARS-CoV-2 infection (PASC). …”
  16. 19836
  17. 19837
  18. 19838

    Table 5_Establishment and validation of the prediction model based on lymphocyte subsets for acute kidney injury in sepsis patients.docx by Leyi Wang (408009)

    Published 2025
    “…Differences in clinical variables and lymphocyte subsets between AKI and non-AKI groups were analyzed. A predictive model was developed using LASSO and multivariate logistic regression and validated internally (5-fold cross-validation) and externally. …”
  19. 19839
  20. 19840